NASDAQ
Astria Therapeutics, Inc. (ATXS) has a free cash flow growth of 11.88% as of Friday, May 29, 2026. This represents a 136.72% increase compared to its 12-month average of -32.35%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.